Cynicism about our species comes cheap. Usually history revolves in cycles because humanity doesn’t learn its lessons. This isn’t one of those times. Sometimes we do solve our problems and avoid catastrophe before it arrives, and these resolutions can often by recycled and revised if the problem is set to reoccur.
A $6.4 trillion price tag, means that adventures-in-the-middle east cost each U.S. tax-payer USD $42,000. The median U.S household has only $11,700 in savings. 29% of U.S. households have less than $1,000 in savings.
Lately, I’ve been making a point of asking those around me, when the conversation inevitably turns to stocks, “what’s your current exposure to equities?”
When a cannabis company loses a lot of money every quarter, and has to sell real estate, cancel acquisitions, lay off staff, renegotiate existing financing to higher interest rates and offer stock to new financiers at a discount to the market price, all to stay afloat, one might expect their newsflow to show bold new moves, innovation, maybe some hard austerity decisions.
Two hundred years after the Sherman Anti-trust Act brought about the fall of Rockefeller’s monopoly control, Bernie Saunders and Elizabeth Warren pushed for America to once again decide whether Pepsi (PEP.NASDAQ), Nestle (NESN.SWX) and Amazon (AMZN.NASDAQ) are agreeable corporate spouses or abusive partners slipping in after a trial separation, but in the age of post-modern capitalism are they just promoting ineffective black-and-white partisan politics in a complex world of grays?
Christmas is one of those holidays where all reason and common sense go out the window. We reconcile with toxic relatives in the spirit of the holidays, we buy expensive gifts for other people, and generally engage in prosocial behaviour out of a weird social admixture of guilt and goodwill. Most of the rules of common sense tend to be suspended for the holidays.
In this sometimes bizarre microcap world we exist in, we’re often presented with ideas and plans that, at first glance, look like craziness.
Medical Marijuana’s (MJNA.OTC) investment arm acquisition of oncology biotech company continues cancer fight
Medical Marijuana (MJNA.OTC) announced today that their investment company AXIM Biotechnologies (AXIM.OTC) has signed a binding term sheet to acquire oncology research and development company Sapphire Biotech.
Cannabis investors exhibit the same psychological characteristics as Dutch teenagers, a “volatile mix of anxiety, irritability, exuberance and despair.” With teenagers, the irrational mood swings are due to “stress points around the uneasy transition toward adulthood.” Cannabis investors don’t have this excuse.
Eli Lilly and company (LLY.NYSE) and robotic cloud-computing provider, Strateos, unveiled the Lilly Life Sciences Studio lab, a new robotic laboratory in San Diego, Calfornia, designed to accelerate the drug discovery process today.
New Experion (EXP.V) CEO lays out the real definition of cannabis 2.0… cost controls and common sense
Sick of hearing about how cannabis companies are 'on the cusp of something great' and 'leading the industry'? Well Experion's new CEO has gone another way: Truth.